Home Tags AbbVie

Tag: AbbVie

AbbVie revealed on Wednesday that it had halted patient enrollment in a late-stage clinical trial for a small-cell lung cancer drug after poor patient outcomes.

A cancer drug that AbbVie acquired in a $10 billion deal is looking more and more like a failure

AbbVie just stopped enrolling patients in a late-stage trial of a high-profile lung cancer drug after patients had shorter survival results on the drug.

A company that’s taking a new approach to tackling Alzheimer’s is moving into human trials after raising $133 million

Biotech startup Alector is getting ready to put its first batch of neurodegenerative drugs into humans after raising an additional $133 million. Alector is developing treatments that harness the body's immune system to tackle conditions like Alzheimer's, and other forms of dementia.
Instead of turning to surgery, drugmakers are hoping to treat diseases like uterine fibroids and endometriosis with new medications.

A new treatment for a condition that can feel like tiny people skating on razor blades in your stomach and affects an estimated 200 million women just...

The FDA just approved elagolix, a new treatment for women living with endometriosis. Endometriosis, a condition that affects millions of women, occurs when tissue from the uterus grows outside of it, leading to cysts, heavy bleeding, and scarring.
Instead of turning to surgery, drugmakers are hoping to treat diseases like uterine fibroids and endometriosis with new medications.

‘Nobody’s talking about’ 2 medical conditions that affect 8 million women in America — but that could be about to change

The drugs in development are to treat two major women's health conditions: endometriosis and uterine fibroids.

RANKED: These are the most and least reputable drug companies in the world

The Reputation Institute took a look at what the general public thought of 17 major pharmaceutical companies. Here's who came out on top.

Here’s the cancer data that led AbbVie to make the 2nd-largest acquisition in the history of venture capital

Stemcentrx wants to target cancer stem cells to treat a form of lung cancer — and we just got more data showing how it works.

RANKED: These are the most and least reputable drug companies in the world

The Reputation Institute took a look at what the general public thought of 14 major pharmaceutical companies. Here's who came out on top.

The second-largest acquisition in the history of venture capital happened today — here’s why a pharma giant paid $10 billion for a startup...

Stemcentrx, a former Sillicon Valley unicorn, is developing drugs that go after cancer stem cells. Here's why AbbVie thinks that's a good idea.

The FDA just approved a new cancer drug — here’s what you need to know about it

AbbVie's venetoclax just got approved for chronic lymphocytic leukemia in people with a specific genetic tweak called a 17p deletion.

New York’s attorney general is investigating whether insurance companies may be unfairly limiting coverage for a costly drug

The New York state Attorney General's office on Wednesday asked 16 health insurers for information related to patients who've been denied hepatitis C drugs.